Worst part is there's no sign of an end game... I know all about the tech but have no clue what the plan to do with it is. I don't doubt this will rise again at some point or another... question is when right...or are they gonna keep using shareholders as main source of funding? I lightened my load significantly on the last run... to .12 knowing the trials were gonna need more $ and didn't expect Collier to come through with proper finance. (Told some of my closet friends to do the same) I'm always watching maybe one day I'll go big here again. But I'm gonna need a very good update to do so. I.e proper funding and or a much larger clinical. (Larger data sample)
News 
Market Data 
Discover 
